(Reuters) – An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster.
America’s gun violence problem is evident nationwide, but a new study reveals that how different groups of people across the country experience such violence can vary dramatically, depending upon who they are and where they live.
William Halford had spent two decades researching and developing a vaccine that he believed could bring relief to the millions of people afflicted with herpes.
(Reuters) – A soldier wounded by an improvised explosive device in Afghanistan has received the world’s first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.
The CDC warns that an outbreak of E. coli is now connected to all types of romaine lettuce, including whole heads and hearts of romaine, as well as chopped romaine in salads and salad mixes.
BUDAPEST (Reuters) – A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly Ebola virus but has shown no symptoms so far, health officials said on Friday.
In one night, the Savage family lost two sons to opioid overdoses. Now they are working to prevent other families from experiencing the same pain.
(Reuters Health) – Many children hospitalized in the U.S. for brain injuries don’t receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.
BOSTON (Reuters) – Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.